EP3505174
Deoxýnúkleósíðmeðferð fyrir sjúkdóma sem orsakast af vanstilltum kirnasöfnum þar meðtöldu heilkenni hvatbera-DNA-þurrðar
:
EP einkaleyfi í gildi á Íslandi:
17.6.2016:
29.4.2020:
19156021.8
:
2.7.2020:
15.7.2020
:
16.6.2036:
16.6.2026:
30.6.2026
:
DEOXYNUCLEOSIDE THERAPY FOR DISEASES CAUSED BY UNBALANCED NUCLEOTIDE POOLS INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES
17.6.2016
29.4.2020
2.7.2020
15.7.2020
16.6.2026
:
The Trustees of Columbia University in the City of New York:
412 Low Memorial Library 535 West 116th Street, New York, NY 10027, US
:
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca:
Passeig Vall d'Hebrón, 119-129, 08035 Barcelona, ES
:
HIRANO, Michio:
New York, NY New York 10033, US
:
GARONE, Caterina:
Cambridge, Cambridgeshire CB1 3RE, GB
:
MARTI, Ramon:
08035 Barcelona, ES
:
Patice ehf.:
Pósthólf 8236, 128, Reykjavík,
:
201562180914 P:
17.6.2015:
US
:
A61K 31/7068, A61K 31/7064, A61K 31/7072, A61P 21/00, A61P 43/00, A61K 31/513, A61K 31/7076, A61K 31/708
: 5
: 23.6.2020
: 16.6.2021
: Árnason Faktor ehf.
: 6
: 24.6.2021
: 16.6.2022
: Árnason Faktor ehf.
: 7
: 28.6.2022
: 16.6.2023
: Árnason Faktor ehf.
: 8
: 24.5.2023
: 16.6.2024
: Árnason Faktor ehf.
: 9
: 11.6.2024
: 16.6.2025
: G.H. Sigurgeirsson ehf.
: 10
: 10.6.2025
: 16.6.2026
: G.H. Sigurgeirsson ehf.